File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0922-4106(05)80046-X
- Scopus: eid_2-s2.0-58149208639
- PMID: 8666038
- WOS: WOS:A1995TA16800004
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Evidence for potential application of zinc as an antidote to acetaminophen-induced hepatotoxicity
Title | Evidence for potential application of zinc as an antidote to acetaminophen-induced hepatotoxicity |
---|---|
Authors | |
Keywords | Acetaminophen Alanine aminotransferase Glutathione Hepatotoxicity Malondialdehyde N-acetylcysteine Zinc sulfate |
Issue Date | 1995 |
Citation | European Journal Of Pharmacology - Environmental Toxicology And Pharmacology Section, 1995, v. 293 n. 3, p. 217-224 How to Cite? |
Abstract | The therapeutic application of zinc sulphate as an antidote to acetaminophen overdose was examined in ICR mice. Hepatotoxicity was induced by a single oral dose of acetaminophen (750 mg/kg). Various treatments (normal saline, 15 or 30 mg/kg zinc sulphate, 150 mg/kg N-acetylcysteine, 15 mg/kg zinc sulphate + 150 mg/kg N-acetylcysteine) were given i.p. 1 h after acetaminophen overdose. Serum alanine aminotransferase, hepatic glutathione and malondialdehyde levels were measured before experiments and at various intervals after the administration of acetaminophen. Serum acetaminophen levels were also measured at different time intervals. Zinc sulphate showed protection by dose-dependently reducing alanine aminotransferase and malondialdehyde levels. The drug also partially prevented the depletion of hepatic glutathione. These effects were not as good as those of N-acetylcysteine. However, the combination of zinc sulphate with N-acetylcysteine produced even better protective effects. Furthermore, drug treatments did not affect serum acetaminophen levels. It is concluded that both drugs attenuate acetaminophen-induced hepatic toxicity, and the action is likely to be mediated through replenishment of hepatic glutathione levels. The use of zinc sulphate alone or in combination with N-acetylcysteine could be another alternative for the treatment of acetaminophen overdose in view of possible side effects produced by N-acetylcysteine. |
Persistent Identifier | http://hdl.handle.net/10722/157272 |
ISSN | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woo, PCY | en_US |
dc.contributor.author | Kaan, SK | en_US |
dc.contributor.author | Cho, CH | en_US |
dc.date.accessioned | 2012-08-08T08:48:33Z | - |
dc.date.available | 2012-08-08T08:48:33Z | - |
dc.date.issued | 1995 | en_US |
dc.identifier.citation | European Journal Of Pharmacology - Environmental Toxicology And Pharmacology Section, 1995, v. 293 n. 3, p. 217-224 | en_US |
dc.identifier.issn | 0926-6917 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/157272 | - |
dc.description.abstract | The therapeutic application of zinc sulphate as an antidote to acetaminophen overdose was examined in ICR mice. Hepatotoxicity was induced by a single oral dose of acetaminophen (750 mg/kg). Various treatments (normal saline, 15 or 30 mg/kg zinc sulphate, 150 mg/kg N-acetylcysteine, 15 mg/kg zinc sulphate + 150 mg/kg N-acetylcysteine) were given i.p. 1 h after acetaminophen overdose. Serum alanine aminotransferase, hepatic glutathione and malondialdehyde levels were measured before experiments and at various intervals after the administration of acetaminophen. Serum acetaminophen levels were also measured at different time intervals. Zinc sulphate showed protection by dose-dependently reducing alanine aminotransferase and malondialdehyde levels. The drug also partially prevented the depletion of hepatic glutathione. These effects were not as good as those of N-acetylcysteine. However, the combination of zinc sulphate with N-acetylcysteine produced even better protective effects. Furthermore, drug treatments did not affect serum acetaminophen levels. It is concluded that both drugs attenuate acetaminophen-induced hepatic toxicity, and the action is likely to be mediated through replenishment of hepatic glutathione levels. The use of zinc sulphate alone or in combination with N-acetylcysteine could be another alternative for the treatment of acetaminophen overdose in view of possible side effects produced by N-acetylcysteine. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | European Journal of Pharmacology - Environmental Toxicology and Pharmacology Section | en_US |
dc.subject | Acetaminophen | - |
dc.subject | Alanine aminotransferase | - |
dc.subject | Glutathione | - |
dc.subject | Hepatotoxicity | - |
dc.subject | Malondialdehyde | - |
dc.subject | N-acetylcysteine | - |
dc.subject | Zinc sulfate | - |
dc.subject.mesh | Acetaminophen - Blood - Toxicity | en_US |
dc.subject.mesh | Acetylcysteine - Pharmacology | en_US |
dc.subject.mesh | Alanine Transaminase - Blood | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antidotes - Pharmacology | en_US |
dc.subject.mesh | Dose-Response Relationship, Drug | en_US |
dc.subject.mesh | Drug Therapy, Combination | en_US |
dc.subject.mesh | Drug-Induced Liver Injury - Blood - Pathology - Prevention & Control | en_US |
dc.subject.mesh | Glutathione - Metabolism | en_US |
dc.subject.mesh | Liver - Drug Effects - Metabolism - Pathology | en_US |
dc.subject.mesh | Malondialdehyde - Metabolism | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Mice, Inbred Icr | en_US |
dc.subject.mesh | Overdose | en_US |
dc.subject.mesh | Sulfates - Pharmacology | en_US |
dc.subject.mesh | Zinc Compounds - Pharmacology | en_US |
dc.subject.mesh | Zinc Sulfate | en_US |
dc.title | Evidence for potential application of zinc as an antidote to acetaminophen-induced hepatotoxicity | en_US |
dc.type | Article | en_US |
dc.identifier.email | Woo, PCY:pcywoo@hkucc.hku.hk | en_US |
dc.identifier.authority | Woo, PCY=rp00430 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0922-4106(05)80046-X | - |
dc.identifier.pmid | 8666038 | - |
dc.identifier.scopus | eid_2-s2.0-58149208639 | en_US |
dc.identifier.volume | 293 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 217 | en_US |
dc.identifier.epage | 224 | en_US |
dc.identifier.isi | WOS:A1995TA16800004 | - |
dc.identifier.scopusauthorid | Woo, PCY=7201801340 | en_US |
dc.identifier.scopusauthorid | Kaan, SK=6603358809 | en_US |
dc.identifier.scopusauthorid | Cho, CH=7403100461 | en_US |
dc.identifier.issnl | 0926-6917 | - |